Drugs / Vaxigrip vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT05895955 Comparator | Nov 2023 → Mar 2024 overdue | influenza | Mahidol University | Active not recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vaxigrip vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05895955 ↗ |
| Modality | Vaccine | “Vaxigrip vaccine is commercially available seasonal quadrivalent inactivated split virion influenza vaccine” NCT05895955 ↗ |
| Route | Intramuscular | “to be administered by intramuscular (IM) injection.” NCT05895955 ↗ |